35801732|t|A narrative review on sacubitril/valsartan and ventricular arrhythmias.
35801732|a|Sacubitril/valsartan, the first angiotensin receptor neprilysin inhibitor approved by the Food and Drug Administration for marketing, has been shown to reduce the risk of cardiovascular death or heart failure hospitalization and improve symptoms in patients with chronic heart failure with a reduced ejection fraction. However, some researchers have also found that sacubitril/valsartan has an antiarrhythmic effect. The mechanism by which sacubitril/valsartan reduces the mortality associated with malignant ventricular arrhythmias is not precise. Many studies have concluded that ventricular arrhythmia is associated with a reduction in myocardial fibrosis. This article reviews the current understanding of the effects of sacubitril/valsartan on the reduction of ventricular arrhythmia and explains its possible mechanisms. The results of this study suggest that sacubitril/valsartan reduces the occurrence of appropriate implantable cardioverter-defibrillator shocks. Meanwhile, sacubitril/valsartan may reduce the occurrence of ventricular arrhythmias by affecting 3 pathways of B-type natriuretic peptide, Angiotensin II, and Bradykinin. The conclusion of this study is that sacubitril/valsartan reduces the number of implantable cardioverter-defibrillator shocks and ventricular arrhythmias in heart failure with reduced ejection fraction patients.
35801732	22	42	sacubitril/valsartan	Chemical	MESH:C549068
35801732	47	70	ventricular arrhythmias	Disease	MESH:D001145
35801732	72	92	Sacubitril/valsartan	Chemical	MESH:C549068
35801732	243	263	cardiovascular death	Disease	MESH:D002318
35801732	267	280	heart failure	Disease	MESH:D006333
35801732	321	329	patients	Species	9606
35801732	343	356	heart failure	Disease	MESH:D006333
35801732	438	458	sacubitril/valsartan	Chemical	MESH:C549068
35801732	512	532	sacubitril/valsartan	Chemical	MESH:C549068
35801732	571	580	malignant	Disease	MESH:D009369
35801732	581	604	ventricular arrhythmias	Disease	MESH:D001145
35801732	654	676	ventricular arrhythmia	Disease	MESH:D001145
35801732	711	730	myocardial fibrosis	Disease	MESH:D005355
35801732	797	817	sacubitril/valsartan	Chemical	MESH:C549068
35801732	838	860	ventricular arrhythmia	Disease	MESH:D001145
35801732	938	958	sacubitril/valsartan	Chemical	MESH:C549068
35801732	1055	1075	sacubitril/valsartan	Chemical	MESH:C549068
35801732	1105	1128	ventricular arrhythmias	Disease	MESH:D001145
35801732	1184	1198	Angiotensin II	Gene	183
35801732	1204	1214	Bradykinin	Gene	3827
35801732	1253	1273	sacubitril/valsartan	Chemical	MESH:C549068
35801732	1346	1369	ventricular arrhythmias	Disease	MESH:D001145
35801732	1373	1386	heart failure	Disease	MESH:D006333
35801732	1418	1426	patients	Species	9606
35801732	Association	MESH:C549068	3827
35801732	Association	MESH:D001145	183
35801732	Association	MESH:C549068	183
35801732	Negative_Correlation	MESH:C549068	MESH:D001145
35801732	Negative_Correlation	MESH:C549068	MESH:D009369
35801732	Negative_Correlation	MESH:C549068	MESH:D002318
35801732	Association	MESH:D001145	3827
35801732	Negative_Correlation	MESH:C549068	MESH:D006333

